XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Condensed Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Sep. 28, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Net sales $ 138,964 $ 120,794 $ 419,638 $ 376,922
Cost of sales (including depreciation and amortization of $10,206, $11,506, $31,252 and $38,146, respectively) 45,413 41,944 134,068 135,030
Gross profit 93,551 78,850 285,570 241,892
Selling, general and administrative expense 81,090 69,820 254,281 225,522
Research and development expense 3,808 3,015 10,393 10,184
Restructuring costs 0 (26) 0 911
Change in fair value of contingent consideration 483 (98) 1,078 429
Depreciation and amortization 2,065 2,317 5,884 6,740
Impairments of assets 2,031 0 33,901 78,615
Loss on disposals 0 1,404 0 2,381
Operating income (loss) 4,074 2,418 (19,967) (82,890)
Interest expense, net 9,532 10,115 29,795 30,396
Other (income) expense (626) 494 (404) (581)
Other expense 8,906 10,609 29,391 29,815
Loss before income taxes (4,832) (8,191) (49,358) (112,705)
Income tax expense (benefit), net 589 600 (5,843) 835
Net loss from continuing operations (5,421) (8,791) (43,515) (113,540)
Loss from discontinued operations, net of tax 0 0 0 (74,429)
Net loss (5,421) (8,791) (43,515) (187,969)
Loss attributable to noncontrolling interest - continuing operations 597 1,488 10,129 22,898
Loss attributable to noncontrolling interest - discontinued operations 0 0 0 14,937
Net loss attributable to Bioventus Inc. (4,824) (7,303) (33,386) (150,134)
Change in foreign currency translation adjustments 575 (324) (436) 636
Comprehensive loss (4,846) (9,115) (43,951) (187,333)
Comprehensive loss attributable to noncontrolling interest - continuing operations 484 1,544 10,216 22,769
Comprehensive loss attributable to noncontrolling interest - discontinued operations 0 0 0 14,937
Comprehensive loss attributable to Bioventus Inc. $ (4,362) $ (7,571) $ (33,735) $ (149,627)
Loss per share of Class A common stock        
Loss per share of Class A common stock from continuing operations, basic (in dollars per share) $ (0.07) $ (0.12) $ (0.52) $ (1.45)
Loss per share of Class A common stock from continuing operations, diluted (in dollars per share) (0.07) (0.12) (0.52) (1.45)
Loss per share of Class A common stock from discontinuing operations, basic (in dollars per share) 0 0 0 (0.95)
Loss per share of Class A common stock from discontinuing operations, diluted (in dollars per share) 0 0 0 (0.95)
Net loss per share of class A common stock, basic (in dollars per share) (0.07) (0.12) (0.52) (2.40)
Loss per share of class A common stock, diluted (in dollars per share) $ (0.07) $ (0.12) $ (0.52) $ (2.40)
Weighted-average shares of Class A common stock outstanding        
Basic (in shares) 65,258,427 62,824,318 64,234,922 62,494,686
Diluted (in shares) 65,258,427 62,824,318 64,234,922 62,494,686